CREATINE KINASE & LACTATE DEHYDROGENASE Flashcards
(94 cards)
CREATINE KINASE (CK)
EC
EC 2.7.3.2
CK
Also known as:
Creatine Phosphokinase
ATP:Creatine N-phosphotransferase
CK function
ATP regeneration in contractile or transport system
CK
In muscle cells, it is involved in the storage of_______
Each contraction cycle uses _____to produce ATP
high-energy creatine phosphate
creatine phosphate
TISSUE SOURCE
CREATINE KINASE (CK)
• Highest activities in:
Skeletal muscle
Heart muscle
Brain tissue
TISSUE SOURCE
CREATINE KINASE (CK)
Present in much smaller quantities in:
BKPPP GLLUTS
Bladder
Placenta
Gastrointestinal tract
Thyroid
Uterus
Kidney
Lung
Prostate
Spleen
Liver
Pancreas
CREATINE KINASE (CK)
• More specific indicator of disorders than total CK levels
ISOENZYMES
• CK is a dimer; 2 subunits:
“B” for____ and “M” for____
Brain
Muscle
CK exists as three isoenzymes:
CK-BB (brain type)
CK-MB (hybrid type)
CK-MM (muscle type)
СК-BB (СК1)
Brain
gastrointestinal tract
uterus during pregnancy
not usually measurable in serum due to blood-brain barrier
СК-BB (СК1)
CK-MB (CK2)
Heart muscle
elevated levels indicate myocardial damage
CK-MB (CK2)
CK-MM (CK3)
Striated muscle and normal
serum
primary isoenzyme in skeletal muscle
The major isoenzyme in healthy individuals
Significant in myocardial tissue and a good indicator of myocardial damage
CK-MM (CK3)
ISOENZYMES
CREATINE KINASE (CK)
Atypical CK-isoenzymes
Macro-CK
CK-Mi
Complexes of CK-BB with immunoglobulins, often IgG;
age and sex-related
Macro-CK
Found in muscle, brain, liver;
indicates severe illness
CK-Mi
Which travels fastest to the ANODE
BB
Arrange from most to least fastest
BB
MB
Macro
MM
DIAGNOSTIC SIGNIFICANCE
CREATINE KINASE (CK)
• Elevated in disorders of…
cardiac and skeletal muscle
Increased CK
• Common conditions:
Myocardial infarction (MI)
rhabdomyolysis
muscular dystrophy
CK
• Source of greatest elevation:
Duchenne muscular dystrophy
METHODS OF CK ISOENZYME MEASUREMENT
CREATINE KINASE (CK)
1.) ELECTROPHORESIS
2.) ION-EXCHANGE CHROMATOGRAPHY
3.) IMMUNOINHIBITION
4.) IMMUNOASSAYS